Medartis Holding AG (XSWX:MED) Enterprise Value: CHF1,084.4 Mil (As of Jun. 26, 2026) ***


XSWX:MED Medartis Holding AG XSWX:MED
76 GF Score
Price CHF77.10
GF Value CHF105.66
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Medartis Holding AG Enterprise Value?

Medartis Holding AG XSWX:MED +7.08% 76 Enterprise Value is CHF1,084.4 Mil as of Jun. 26, 2026. GuruFocus rates XSWX:MED with a GF Score™ of 76/100 and a GF Value™ of CHF105.66 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Medartis Holding AG's Enterprise Value is CHF1,084.4 Mil. Medartis Holding AG's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was CHF20.3 Mil. Therefore, Medartis Holding AG's EV-to-EBIT ratio for today is 53.51.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Medartis Holding AG's Enterprise Value is CHF1,084.4 Mil. Medartis Holding AG's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was CHF45.7 Mil. Therefore, Medartis Holding AG's EV-to-EBITDA ratio for today is 23.72.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Medartis Holding AG's Enterprise Value is CHF1,084.4 Mil. Medartis Holding AG's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was CHF269.3 Mil. Therefore, Medartis Holding AG's EV-to-Revenue ratio for today is 4.03.

EV-to-OCF is calculated as Enterprise Value divided by its Cash Flow from Operations. As of today, Medartis Holding AG's Enterprise Value is CHF1,084.4 Mil. Medartis Holding AG's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was CHF34.8 Mil. Therefore, Medartis Holding AG's EV-to-OCF ratio for today is 31.14.

EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Medartis Holding AG's Enterprise Value is CHF1,084.4 Mil. Medartis Holding AG's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was CHF9.3 Mil. Therefore, Medartis Holding AG's EV-to-FCF ratio for today is 116.08.

*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.


Medartis Holding AG  (XSWX:MED) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Medartis Holding AG's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=1084.375/20.265
=53.51

Medartis Holding AG's current Enterprise Value is CHF1,084.4 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Medartis Holding AG's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was CHF20.3 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Medartis Holding AG's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=1084.375/45.716
=23.72

Medartis Holding AG's current Enterprise Value is CHF1,084.4 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Medartis Holding AG's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was CHF45.7 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Medartis Holding AG's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=1084.375/269.257
=4.03

Medartis Holding AG's current Enterprise Value is CHF1,084.4 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Medartis Holding AG's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was CHF269.3 Mil.

4. EV-to-OCF is calculated as Enterprise Value divided by its Cash Flow from Operations.

Medartis Holding AG's EV-to-OCF for today is:

EV-to-OCF=Enterprise Value (Today)/Cash Flow from Operations (TTM)
=1084.375/34.817
=31.14

Medartis Holding AG's current Enterprise Value is CHF1,084.4 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Medartis Holding AG's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was CHF34.8 Mil.

5. EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow.

Medartis Holding AG's EV-to-FCF for today is:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=1084.375/9.342
=116.08

Medartis Holding AG's current Enterprise Value is CHF1,084.4 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Medartis Holding AG's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was CHF9.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medartis Holding AG Enterprise Value Related Terms


Medartis Holding AG Enterprise Value Historical Data

* Premium members only.

The historical data trend for Medartis Holding AG's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medartis Holding AG Enterprise Value Chart

Medartis Holding AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,479.62 979.16 1,039.88 683.70 1,221.34

Medartis Holding AG Semi-Annual Data
Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,039.88 925.52 683.70 1,006.75 1,221.34

XSWX:MED vs ABT, SYK, MDT: Enterprise Value Comparison

For the Medical Devices subindustry, Medartis Holding AG's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medartis Holding AG Enterprise Value vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medartis Holding AG's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Medartis Holding AG's Enterprise Value falls into.


XSWX:MED
76GF Score
Medartis Holding AG XSWX:MED
Enterprise Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medartis Holding AG Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Medartis Holding AG's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as

Medartis Holding AG's Enterprise Value for the quarter that ended in Dec. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Enterprise Value →
What does a Enterprise Value of CHF1,084.4 Mil mean?
Medartis Holding AG (XSWX:MED) has a Enterprise Value of CHF1,084.4 Mil as of Jun. 26, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Medartis Holding AG and its competitors.
Is Medartis Holding AG's Enterprise Value too high?
Medartis Holding AG's current Enterprise Value is CHF1,084.4 Mil. Overall, Medartis Holding AG has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medartis Holding AG's Enterprise Value compare to ABT and SYK?
Medartis Holding AG's Enterprise Value of CHF1,084.4 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Medical Devices & Instruments company?
A good Enterprise Value depends on the Medical Devices & Instruments industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Medartis Holding AG and its competitors. Medartis Holding AG's current Enterprise Value is CHF1,084.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medartis Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Medartis Holding AG (XSWX:MED) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF105.66, compared to a current price of CHF77.10 — trading 27% below its estimated fair value. The current Enterprise Value is CHF1,084.4 Mil. Medartis Holding AG's overall GF Score™ is 76/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Medartis Holding AG (XSWX:MED), the current Enterprise Value is CHF1,084.4 Mil as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medartis Holding AG (XSWX:MED) Overvalued in 2026?

Based on GuruFocus' analysis, Medartis Holding AG stock appears to be undervalued. The current stock price of CHF77.10 is trading 27% below its estimated GF Value™ of CHF105.66. GuruFocus considers Medartis Holding AG to be Modestly Undervalued.

Key valuation signals for XSWX:MED:

  • Enterprise Value: CHF1,084.4 Mil
  • GF Value™: CHF105.66 vs. price of CHF77.10 (27% below fair value)
  • GF Score™: 76/100 with 5 warning signs

No single metric tells the full story. See the XSWX:MED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medartis Holding AG Business Description

Other Exchanges MEDz:UK1RU:Germany
Address Hochbergerstrasse 60E, Basel, CHE, 4057
Medartis Holding AG is a medical device company. The company's product profile is divided into APTUS products, StealthFix Products, and MODUS products. APTUS includes products for the Hand, Wrist, Elbow, Shoulder, and Foot. MODUS comprises products for the mandible. Geographically, it derives the majority of its revenue from Europe, Middle East and Africa (EMEA) and also has a presence in North America, Asia Pacific, and Latin America.
76GF Score

Get the complete analysis for XSWX:MED

Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF77.10
Price
CHF105.66
GF Value